Human Immunology Bioscience

HI-Bio's expectations elevated after pair of phase 2 readouts bolster autoimmune ambitions
Fierce Biotech
Tue, 04/11/23 - 11:36 am
Hi-Bio
Human Immunology Bioscience
kidney disease
felzartamab
Autoimmune drug biotech HI-Bio unveils $120M to root out cellular drivers of disease
MedCity News
Tue, 11/1/22 - 10:55 am
Human Immunology Bioscience
autoimmune disease
R&D
MorphoSys
kidney disease